69097-315 NDC - LAMIVUDINE AND ZIDOVUDINE ()

Drug Information

Product NDC: 69097-315

Proprietary Name: Lamivudine and Zidovudine

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Cipla USA Inc.
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:9/7/2018

Package Information

No. Package Code Package Description Billing Unit
169097-315-0230 TABLET, FILM COATED in 1 BOTTLE (69097-315-02)
269097-315-0360 TABLET, FILM COATED in 1 BOTTLE (69097-315-03)
369097-315-151000 TABLET, FILM COATED in 1 BOTTLE (69097-315-15)
469097-315-2110 BLISTER PACK in 1 BOX, UNIT-DOSE (69097-315-21) / 10 TABLET, FILM COATED in 1 BLISTER PACK

NDC Record

Field Name Field Value Definition
PRODUCT NDC69097-315The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMELamivudine and ZidovudineThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE9/7/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAMECipla USA Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023